News
-
Scientists found element causes SARS virus commit suicide
“Serendipity may be the best description of this crucial finding!”, says Dr. Jim-Min Fang regarding the SARS protease inhibitor found by a group of researchers aiming at drug discovery for SARS.
-
A New Simple and Rapid Way of Finding Potent Enzyme Inhibitors Shows Great Promise in Drug Discovery
Enzymes are proteins that catalyze metabolism and biosynthesis in living systems and are important targets for drug discovery. For instance, the famous neuraminidase inhibitor, Tamiflu, has been prescribed to treat the infection of influenza virus.
-
PSEP Provides better accuracy for cross-species gene prediction
A group of researchers led by Dr. Trees-Juen Chuang from Genomics Research Center of Academia Sinica have developed a new algorithm, PSEP (Progressive Signal Extracting and Patching), which utilizes cross-species approach to identify gene structures and alternatively spliced (AS) variants.
-
New Study of Reishi Polysaccharides Defines the Mechanism and Shows Promise in Drug Development
Researchers in Taiwan have finally unraveled the mode of action of Reishi (Ganoderma lucidium, Ling-Zhi) polysaccharides. Reishi is a valuable Chinese herb medicine traditionally used for promoting good health, vitality and longevity, stimulating the expression of immune cells, enhancing the immuno-modulation activity, and supporting cancer therapy.
-
Taiwan Scientists Discovered Important Plasma Proteome Changes in SARS Patients
The SARS epidemic has brought a great deal of global concern since 2003. Though the virus causing the disease was quickly identified, the pathogenesis of SARS is still a mystery. In order to overcome this problem, scientists from Taiwan performed a proteomic study using plasma samples from patients with SARS to explore the possible pathogenesis of this disease.
-
The inauguration ceremony of Genomis Research Center building
The Genomics Research Center (GRC) of Academia Sinica was founded in January 2003 as a result of a series of promotions for biotechnology led by Dr. Lee Yuan-Tseh, President of Academia Sinica. GRC has a focused mission to integrate physical science and life science, with major emphasis on the discovery and functional study of genes and diseases, development of innovative technologies and therapeutic strategies. Dr. Chi-Huey Wong is currently Director of the Center.
-
Nature Magazine Quotes the GRC Finding on SARS
The notable science magazine “Nature Review, Microbiology” has quoted the PNAS publication about the achievement by the team led by Dr. Chi-Huey Wong regarding their work on drug discovery targeting SARS virus on the September 2004, Vol. 2 No 9 issue.